Signal transduction pathways associated with α1-adrenoceptor subtypes in cells and tissues including human prostate
Signal transduction pathways associated with α1-adrenoceptor subtypes in cells and tissues including human prostate
复制标题
DOI:
10.1159/000052317
复制
发表时间:
1999-01-01
期刊:
影响因子:
23.4
通讯作者:
Chapple, CR
中科院分区:
文献类型:
--
作者:
Marshall, I;Burt, RP;Chapple, CR
The complexity of the signal transduction pathways linked to alpha(1A)-adrenoceptors are becoming clearer. At one time it was thought that the alpha(1A)-subtype was linked to the influx of extracellular Ca2+ while the alpha(1B)-subtype was linked via inosital phosphate formation to the release of intracellular Ca-2. However the coupling of the alpha(1)-adrenoceptors to G-proteins leads to the activation of a number of different effector enzymes which produce intracellular second messengers and alterations in biological activity. One area of diversity is in the many forms of the G alpha, beta, gamma heterotrimeric G-proteins which confer specificity towards certain effecters. All alpha(1)-adrenoceptor subtypes have been shown to couple to phospholipase C in many cells and tissues leading to the breakdown of PiP(2) to give IP3, which releases intraceIlular Ca2+, and diacylglycerol, which stimulates protein kinase C. Additional effecrors which can couple to alpha(1)-adrenoceptors include phosphalipase D, adenylate cyclase and the mitogen-activated protein kinase pathway. The latter involves a longer term response and causes increased cell growth and may be important in, for example, the prostate as well as in vascular smooth muscle and the heart. In human prostate alpha(1)-adrenaceptor activation leads to the release of intracellular Ca2+ from ryanodine-sensitive stare followed by an influx of extracelIular Ca2+, a mechanism different from that linked to the same receptor subtype in several other smooth muscles. Therefore a given alpha(1)-subtype may be coupled to a variety of different signal transduction mechanisms in different systems. Further, there may be different effector mechanisms linked to alpha(1)-subtypes in a given cell or tissue e.g. phospholipase C and mitogen-activated protein kinase. An increased understanding of the complexity of signal transduction mechanisms and the elucidation of the details in a particular tissue will open up new possibilities for therapeutic interventions.